Video Experimental Relacionado
Updated: Sep 10, 2025
03:38
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
322
Los alcaloides como terapias emergentes contra la fibrosis pulmonar: clasificación, mecanismos y potencial de
Yafang Wang1, Chunlei Hua2, Henghui Zhang3
1Department of Rheumatology and Immunology, Inner Mongolia Autonomous Region People's Hospital, Hohhot, China.
Chemistry & biodiversity
|August 20, 2025
Resumen
Los alcaloides naturales son prometedores en el tratamiento de la fibrosis pulmonar (PF) al dirigirse a múltiples vías. Esta revisión sintetiza la investigación sobre sus efectos antiinflamatorios, antioxidantes y antiapoptóticos para la prevención y el tratamiento de la PF.
Área de la Ciencia:
- Farmacología
- Pulmonología
- Productos naturales Química
Sus antecedentes:
- La fibrosis pulmonar (PF) es una enfermedad pulmonar progresiva con opciones de tratamiento limitadas.
- Los productos naturales, especialmente los alcaloides, están surgiendo como agentes terapéuticos potenciales para la PF.
- Los alcaloides ofrecen un enfoque multidireccional para combatir la patología PF.
Objetivo del estudio:
- Revisión sistemática de los mecanismos de acción de los alcaloides en la prevención y el tratamiento de la fibrosis pulmonar.
- Sintetizar los hallazgos actuales de la investigación experimental y clínica sobre las terapias PF basadas en alcaloides.
- Identificar los desafíos y las direcciones de investigación futuras para el desarrollo terapéutico de PF novedoso.
Principales métodos:
- Búsqueda exhaustiva de la literatura de estudios experimentales y clínicos sobre los alcaloides y la fibrosis pulmonar.
- Análisis de las vías de señalización dirigidas por los alcaloides en los modelos de PF.
- Evaluación de los efectos antiinflamatorios, antioxidantes y antiapoptóticos de los alcaloides relacionados con el PF.
Principales resultados:
- Los alcaloides demuestran eficacia en la inhibición de la deposición de la matriz extracelular.
- Protegen las células epiteliales alveolares y suprimen la activación y proliferación de los fibroblastos pulmonares.
- Múltiples vías de señalización son moduladas por alcaloides para ejercer efectos anti-PF.
Conclusiones:
- Los alcaloides representan una clase prometedora de compuestos naturales para el tratamiento de la fibrosis pulmonar.
- Sus mecanismos multi-dirigidos ofrecen ventajas sobre las terapias convencionales.
- Se requiere más investigación para traducir estos hallazgos en aplicaciones clínicas para PF.
Videos de Conceptos Relacionados
01:30Pulmonary Hypertension: Classification and Pathogenesis
285
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
285
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.8K
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
256
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
256
01:26Targets for Drug Action: Overview
7.4K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
7.4K
01:26Drug Discovery: Overview
8.7K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
578
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
578